000 01423 a2200409 4500
005 20250517171407.0
264 0 _c20180503
008 201805s 0 0 eng d
022 _a1940-6029
024 7 _a10.1007/978-1-4939-7113-8_2
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLiu, Tianju
245 0 0 _aThe Bleomycin Model of Pulmonary Fibrosis.
_h[electronic resource]
260 _bMethods in molecular biology (Clifton, N.J.)
_c2017
300 _a27-42 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural
650 0 4 _aAnimals
650 0 4 _aAntibiotics, Antineoplastic
_xadverse effects
650 0 4 _aBleomycin
_xadministration & dosage
650 0 4 _aDisease Models, Animal
650 0 4 _aDisease Progression
650 0 4 _aDrug Administration Routes
650 0 4 _aFemale
650 0 4 _aGenetic Predisposition to Disease
650 0 4 _aHumans
650 0 4 _aIdiopathic Pulmonary Fibrosis
_xetiology
650 0 4 _aLung Diseases, Interstitial
_xetiology
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aPulmonary Fibrosis
_xetiology
650 0 4 _aRats
650 0 4 _aSex Factors
700 1 _aDe Los Santos, Francina Gonzalez
700 1 _aPhan, Sem H
773 0 _tMethods in molecular biology (Clifton, N.J.)
_gvol. 1627
_gp. 27-42
856 4 0 _uhttps://doi.org/10.1007/978-1-4939-7113-8_2
_zAvailable from publisher's website
999 _c27493126
_d27493126